⌘+K

Latest share price

SEK

1.0

-7.12%

20 Nov 2026 17:29 CET

Fair value range

SEK

3.6

—

4.6

2 Oct 2026

Market cap

SEK

654

m

Next report

Q4

18 Feb 2027

Medivir

Healthcare

2026-11-19

Regulatory tailwind from the FDA in OI

The FDA has granted Medivir rare paediatric disease designation (RPDD) for MIV-711 in osteogenesis imperfecta (OI). In our view, the designation strengthens the...

News

Klas Palin

Regulatory tailwind from the FDA in OI

Negative reaction despite undramatic quarter - Q3 review

A broader pipeline, stronger equity story - reinitiating coverage

Medivir

Healthcare

2026-11-06

Negative reaction despite undramatic quarter - Q3 review

There was relatively little news flow in Q3 and costs were broadly in line with our overall expectation. However, the shares fell sharply following the report – we...

Update Note

Klas Palin

Regulatory tailwind from the FDA in OI

Negative reaction despite undramatic quarter - Q3 review

A broader pipeline, stronger equity story - reinitiating coverage

Medivir

Healthcare

2026-10-02

A broader pipeline, stronger equity story - reinitiating coverage

We reinitiate coverage of Medivir with a fair value range of SEK3.6–4.6 per share. Medivir is a mid-stage clinical biotechnology company. Following a transformational...

Initiating Coverage

Klas Palin

Regulatory tailwind from the FDA in OI

Negative reaction despite undramatic quarter - Q3 review

A broader pipeline, stronger equity story - reinitiating coverage

Price chart

Price

Fair range high value

Fair range low value

Year

2024

2025

2026e

2027e

2028e

EPS (Adj.)

-1.12

-0.23

-0.13

-0.15

-0.14

Sales Growth

-50.21%

98.15%

-54.04%

-1.96%

-25.00%

EPS Growth (Adj.)

P/E

P/E (Adj.)

EV/EBITA

-0.5

-3.9

-5.9

-5.4

-6.1

EV/EBITDA

-0.5

-6.0

-6.1

-5.5

-6.2

Learn more

Key facts

Sector

Healthcare

Country

Sweden

Tickers

MVIR@SS, MEDIVIR.ST

CEO

Jens Lindberg

CFO

Patrik Norgren

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB